PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 116 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 4.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $114,000 | -43.6% | 50,000 | -10.7% | 0.02% | -21.1% |
| Q4 2019 | $202,000 | +5.8% | 56,000 | 0.0% | 0.02% | -9.5% |
| Q3 2019 | $191,000 | -27.4% | 56,000 | 0.0% | 0.02% | -19.2% |
| Q2 2019 | $263,000 | +32.8% | 56,000 | -5.4% | 0.03% | +13.0% |
| Q1 2019 | $198,000 | -73.5% | 59,189 | -78.9% | 0.02% | -76.5% |
| Q4 2018 | $747,000 | +295.2% | 281,000 | +1024.0% | 0.10% | +366.7% |
| Q4 2017 | $189,000 | +21.9% | 25,000 | 0.0% | 0.02% | +5.0% |
| Q3 2017 | $155,000 | +22.0% | 25,000 | 0.0% | 0.02% | +17.6% |
| Q2 2017 | $127,000 | +95.4% | 25,000 | 0.0% | 0.02% | +88.9% |
| Q1 2017 | $65,000 | +44.4% | 25,000 | 0.0% | 0.01% | +50.0% |
| Q4 2016 | $45,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |